 | • レポートコード：GIR-2104Z01009 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療機器・消耗品 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、抗レトロウイルス療法のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。抗レトロウイルス療法の種類別市場規模（NNRTI、NRTI、マルチクラスコンビネーション製品、インテグラーゼ阻害剤）、用途別市場規模（病院、診療所、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・抗レトロウイルス療法の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Gilead、F. Hoffmann-La Roche、ViiV Healthcare、Boehringer Ingelheim、Janssen Pharmaceuticals、Mylan、Abbvie、Bionor Pharma、Vertex Pharmaceuticals ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：NNRTI、NRTI、マルチクラスコンビネーション製品、インテグラーゼ阻害剤 ・用途別分析2016年-2026年：病院、診療所、その他 ・抗レトロウイルス療法の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・抗レトロウイルス療法のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・抗レトロウイルス療法のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・抗レトロウイルス療法の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・抗レトロウイルス療法の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Antiretroviral Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Antiretroviral Therapy size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Antiretroviral Therapy market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Antiretroviral Therapy market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
NNRTIs
NRTI
Multiclass Combination Products
Integrase Inhibitors
Market segment by Application can be divided into
Hospital
Clinic
Other
The key market players for global Antiretroviral Therapy market are listed below:
Gilead
F. Hoffmann-La Roche
ViiV Healthcare
Boehringer Ingelheim
Janssen Pharmaceuticals
Mylan
Abbvie
Bionor Pharma
Vertex Pharmaceuticals
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Antiretroviral Therapy Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Antiretroviral Therapy Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 NNRTIs
1.2.3 NRTI
1.2.4 Multiclass Combination Products
1.2.5 Integrase Inhibitors
1.3 Market Analysis by Application
1.3.1 Overview: Global Antiretroviral Therapy Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Antiretroviral Therapy Market Size & Forecast
1.4.1 Global Antiretroviral Therapy Sales in Value (2016-2026))
1.4.2 Global Antiretroviral Therapy Sales in Volume (2016-2026)
1.4.3 Global Antiretroviral Therapy Price by Type (2016-2026) & (USD/MT)
1.5 Global Antiretroviral Therapy Production Capacity Analysis
1.5.1 Global Antiretroviral Therapy Total Production Capacity (2016-2026)
1.5.2 Global Antiretroviral Therapy Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Antiretroviral Therapy Market Drivers
1.6.2 Antiretroviral Therapy Market Restraints
1.6.3 Antiretroviral Therapy Trends Analysis
2 Manufacturers Profiles
2.1 Gilead
2.1.1 Gilead Details
2.1.2 Gilead Major Business
2.1.3 Gilead Antiretroviral Therapy Product and Services
2.1.4 Gilead Antiretroviral Therapy Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 F. Hoffmann-La Roche
2.2.1 F. Hoffmann-La Roche Details
2.2.2 F. Hoffmann-La Roche Major Business
2.2.3 F. Hoffmann-La Roche Antiretroviral Therapy Product and Services
2.2.4 F. Hoffmann-La Roche Antiretroviral Therapy Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 ViiV Healthcare
2.3.1 ViiV Healthcare Details
2.3.2 ViiV Healthcare Major Business
2.3.3 ViiV Healthcare Antiretroviral Therapy Product and Services
2.3.4 ViiV Healthcare Antiretroviral Therapy Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Boehringer Ingelheim
2.4.1 Boehringer Ingelheim Details
2.4.2 Boehringer Ingelheim Major Business
2.4.3 Boehringer Ingelheim Antiretroviral Therapy Product and Services
2.4.4 Boehringer Ingelheim Antiretroviral Therapy Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Janssen Pharmaceuticals
2.5.1 Janssen Pharmaceuticals Details
2.5.2 Janssen Pharmaceuticals Major Business
2.5.3 Janssen Pharmaceuticals Antiretroviral Therapy Product and Services
2.5.4 Janssen Pharmaceuticals Antiretroviral Therapy Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Mylan
2.6.1 Mylan Details
2.6.2 Mylan Major Business
2.6.3 Mylan Antiretroviral Therapy Product and Services
2.6.4 Mylan Antiretroviral Therapy Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Abbvie
2.7.1 Abbvie Details
2.7.2 Abbvie Major Business
2.7.3 Abbvie Antiretroviral Therapy Product and Services
2.7.4 Abbvie Antiretroviral Therapy Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Bionor Pharma
2.8.1 Bionor Pharma Details
2.8.2 Bionor Pharma Major Business
2.8.3 Bionor Pharma Antiretroviral Therapy Product and Services
2.8.4 Bionor Pharma Antiretroviral Therapy Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Vertex Pharmaceuticals
2.9.1 Vertex Pharmaceuticals Details
2.9.2 Vertex Pharmaceuticals Major Business
2.9.3 Vertex Pharmaceuticals Antiretroviral Therapy Product and Services
2.9.4 Vertex Pharmaceuticals Antiretroviral Therapy Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Antiretroviral Therapy Sales by Manufacturer
3.1 Global Antiretroviral Therapy Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Antiretroviral Therapy Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Antiretroviral Therapy
3.4 Market Concentration Rate
3.4.1 Top 3 Antiretroviral Therapy Manufacturer Market Share
3.4.2 Top 6 Antiretroviral Therapy Manufacturer Market Share
3.5 Global Antiretroviral Therapy Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Antiretroviral Therapy Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Antiretroviral Therapy Market Size by Region
4.1.1 Global Antiretroviral Therapy Sales in Volume by Region (2016-2026)
4.1.2 Global Antiretroviral Therapy Revenue by Region (2016-2026)
4.2 North America Antiretroviral Therapy Revenue (2016-2026)
4.3 Europe Antiretroviral Therapy Revenue (2016-2026)
4.4 Asia-Pacific Antiretroviral Therapy Revenue (2016-2026)
4.5 South America Antiretroviral Therapy Revenue (2016-2026)
4.6 Middle East and Africa Antiretroviral Therapy Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Antiretroviral Therapy Sales in Volume by Type (2016-2026)
5.2 Global Antiretroviral Therapy Revenue by Type (2016-2026)
5.3 Global Antiretroviral Therapy Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Antiretroviral Therapy Sales in Volume by Application (2016-2026)
6.2 Global Antiretroviral Therapy Revenue by Application (2016-2026)
6.3 Global Antiretroviral Therapy Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Antiretroviral Therapy Sales by Type (2016-2026)
7.2 North America Antiretroviral Therapy Sales by Application (2016-2026)
7.3 North America Antiretroviral Therapy Market Size by Country
7.3.1 North America Antiretroviral Therapy Sales in Volume by Country (2016-2026)
7.3.2 North America Antiretroviral Therapy Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Antiretroviral Therapy Sales by Type (2016-2026)
8.2 Europe Antiretroviral Therapy Sales by Application (2016-2026)
8.3 Europe Antiretroviral Therapy Market Size by Country
8.3.1 Europe Antiretroviral Therapy Sales in Volume by Country (2016-2026)
8.3.2 Europe Antiretroviral Therapy Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Antiretroviral Therapy Sales by Type (2016-2026)
9.2 Asia-Pacific Antiretroviral Therapy Sales by Application (2016-2026)
9.3 Asia-Pacific Antiretroviral Therapy Market Size by Region
9.3.1 Asia-Pacific Antiretroviral Therapy Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Antiretroviral Therapy Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Antiretroviral Therapy Sales by Type (2016-2026)
10.2 South America Antiretroviral Therapy Sales by Application (2016-2026)
10.3 South America Antiretroviral Therapy Market Size by Country
10.3.1 South America Antiretroviral Therapy Sales in Volume by Country (2016-2026)
10.3.2 South America Antiretroviral Therapy Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Antiretroviral Therapy Sales by Type (2016-2026)
11.2 Middle East & Africa Antiretroviral Therapy Sales by Application (2016-2026)
11.3 Middle East & Africa Antiretroviral Therapy Market Size by Country
11.3.1 Middle East & Africa Antiretroviral Therapy Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Antiretroviral Therapy Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Antiretroviral Therapy Typical Distributors
12.3 Antiretroviral Therapy Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Antiretroviral Therapy Revenue by Type, (USD Million), 2021-2026
Table 2. Global Antiretroviral Therapy Revenue by Application, (USD Million), 2021-2026
Table 3. Gilead Basic Information, Manufacturing Base and Competitors
Table 4. Gilead Major Business
Table 5. Gilead Antiretroviral Therapy Product and Services
Table 6. Gilead Antiretroviral Therapy Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. F. Hoffmann-La Roche Basic Information, Manufacturing Base and Competitors
Table 8. F. Hoffmann-La Roche Major Business
Table 9. F. Hoffmann-La Roche Antiretroviral Therapy Product and Services
Table 10. F. Hoffmann-La Roche Antiretroviral Therapy Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. ViiV Healthcare Basic Information, Manufacturing Base and Competitors
Table 12. ViiV Healthcare Major Business
Table 13. ViiV Healthcare Antiretroviral Therapy Product and Services
Table 14. ViiV Healthcare Antiretroviral Therapy Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 16. Boehringer Ingelheim Major Business
Table 17. Boehringer Ingelheim Antiretroviral Therapy Product and Services
Table 18. Boehringer Ingelheim Antiretroviral Therapy Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Janssen Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 20. Janssen Pharmaceuticals Major Business
Table 21. Janssen Pharmaceuticals Antiretroviral Therapy Product and Services
Table 22. Janssen Pharmaceuticals Antiretroviral Therapy Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Mylan Basic Information, Manufacturing Base and Competitors
Table 24. Mylan Major Business
Table 25. Mylan Antiretroviral Therapy Product and Services
Table 26. Mylan Antiretroviral Therapy Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Abbvie Basic Information, Manufacturing Base and Competitors
Table 28. Abbvie Major Business
Table 29. Abbvie Antiretroviral Therapy Product and Services
Table 30. Abbvie Antiretroviral Therapy Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Bionor Pharma Basic Information, Manufacturing Base and Competitors
Table 32. Bionor Pharma Major Business
Table 33. Bionor Pharma Antiretroviral Therapy Product and Services
Table 34. Bionor Pharma Antiretroviral Therapy Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Vertex Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 36. Vertex Pharmaceuticals Major Business
Table 37. Vertex Pharmaceuticals Antiretroviral Therapy Product and Services
Table 38. Vertex Pharmaceuticals Antiretroviral Therapy Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Global Antiretroviral Therapy Sales by Manufacturer (2019-2021e) & (K MT)
Table 40. Global Antiretroviral Therapy Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 41. Market Position of Manufacturers in Antiretroviral Therapy, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 42. Global Antiretroviral Therapy Production Capacity by Company, (K MT): 2020 VS 2021
Table 43. Head Office and Antiretroviral Therapy Production Site of Key Manufacturer
Table 44. Global Antiretroviral Therapy Sales by Region (2016-2021e) & (K MT)
Table 45. Global Antiretroviral Therapy Sales by Region (2021-2026) & (K MT)
Table 46. Global Antiretroviral Therapy Revenue by Region (2016-2021e) & (USD Million)
Table 47. Global Antiretroviral Therapy Revenue by Region (2021-2026) & (USD Million)
Table 48. Global Antiretroviral Therapy Sales by Type (2016-2021e) & (K MT)
Table 49. Global Antiretroviral Therapy Sales by Type (2021-2026) & (K MT)
Table 50. Global Antiretroviral Therapy Revenue by Type (2016-2021e) & (USD Million)
Table 51. Global Antiretroviral Therapy Revenue by Type (2021-2026) & (USD Million)
Table 52. Global Antiretroviral Therapy Price by Type (2016-2021e) & (USD/MT)
Table 53. Global Antiretroviral Therapy Price by Type (2021-2026) & (USD/MT)
Table 54. Global Antiretroviral Therapy Sales by Application (2016-2021e) & (K MT)
Table 55. Global Antiretroviral Therapy Sales by Application (2021-2026) & (K MT)
Table 56. Global Antiretroviral Therapy Revenue by Application (2016-2021e) & (USD Million)
Table 57. Global Antiretroviral Therapy Revenue by Application (2021-2026) & (USD Million)
Table 58. Global Antiretroviral Therapy Price by Application (2016-2021e) & (USD/MT)
Table 59. Global Antiretroviral Therapy Price by Application (2021-2026) & (USD/MT)
Table 60. North America Antiretroviral Therapy Sales by Country (2016-2021e) & (K MT)
Table 61. North America Antiretroviral Therapy Sales by Country (2021-2026) & (K MT)
Table 62. North America Antiretroviral Therapy Revenue by Country (2016-2021e) & (USD Million)
Table 63. North America Antiretroviral Therapy Revenue by Country (2021-2026) & (USD Million)
Table 64. North America Antiretroviral Therapy Sales by Type (2016-2021e) & (K MT)
Table 65. North America Antiretroviral Therapy Sales by Type (2021-2026) & (K MT)
Table 66. North America Antiretroviral Therapy Sales by Application (2016-2021e) & (K MT)
Table 67. North America Antiretroviral Therapy Sales by Application (2021-2026) & (K MT)
Table 68. Europe Antiretroviral Therapy Sales by Country (2016-2021e) & (K MT)
Table 69. Europe Antiretroviral Therapy Sales by Country (2021-2026) & (K MT)
Table 70. Europe Antiretroviral Therapy Revenue by Country (2016-2021e) & (USD Million)
Table 71. Europe Antiretroviral Therapy Revenue by Country (2021-2026) & (USD Million)
Table 72. Europe Antiretroviral Therapy Sales by Type (2016-2021e) & (K MT)
Table 73. Europe Antiretroviral Therapy Sales by Type (2021-2026) & (K MT)
Table 74. Europe Antiretroviral Therapy Sales by Application (2016-2021e) & (K MT)
Table 75. Europe Antiretroviral Therapy Sales by Application (2021-2026) & (K MT)
Table 76. Asia-Pacific Antiretroviral Therapy Sales by Region (2016-2021e) & (K MT)
Table 77. Asia-Pacific Antiretroviral Therapy Sales by Region (2021-2026) & (K MT)
Table 78. Asia-Pacific Antiretroviral Therapy Revenue by Region (2016-2021e) & (USD Million)
Table 79. Asia-Pacific Antiretroviral Therapy Revenue by Region (2021-2026) & (USD Million)
Table 80. Asia-Pacific Antiretroviral Therapy Sales by Type (2016-2021e) & (K MT)
Table 81. Asia-Pacific Antiretroviral Therapy Sales by Type (2021-2026) & (K MT)
Table 82. Asia-Pacific Antiretroviral Therapy Sales by Application (2016-2021e) & (K MT)
Table 83. Asia-Pacific Antiretroviral Therapy Sales by Application (2021-2026) & (K MT)
Table 84. South America Antiretroviral Therapy Sales by Country (2016-2021e) & (K MT)
Table 85. South America Antiretroviral Therapy Sales by Country (2021-2026) & (K MT)
Table 86. South America Antiretroviral Therapy Revenue by Country (2016-2021e) & (USD Million)
Table 87. South America Antiretroviral Therapy Revenue by Country (2021-2026) & (USD Million)
Table 88. South America Antiretroviral Therapy Sales by Type (2016-2021e) & (K MT)
Table 89. South America Antiretroviral Therapy Sales by Type (2021-2026) & (K MT)
Table 90. South America Antiretroviral Therapy Sales by Application (2016-2021e) & (K MT)
Table 91. South America Antiretroviral Therapy Sales by Application (2021-2026) & (K MT)
Table 92. Middle East & Africa Antiretroviral Therapy Sales by Country (2016-2021e) & (K MT)
Table 93. Middle East & Africa Antiretroviral Therapy Sales by Country (2021-2026) & (K MT)
Table 94. Middle East & Africa Antiretroviral Therapy Revenue by Country (2016-2021e) & (USD Million)
Table 95. Middle East & Africa Antiretroviral Therapy Revenue by Country (2021-2026) & (USD Million)
Table 96. Middle East & Africa Antiretroviral Therapy Sales by Type (2016-2021e) & (K MT)
Table 97. Middle East & Africa Antiretroviral Therapy Sales by Type (2021-2026) & (K MT)
Table 98. Middle East & Africa Antiretroviral Therapy Sales by Application (2016-2021e) & (K MT)
Table 99. Middle East & Africa Antiretroviral Therapy Sales by Application (2021-2026) & (K MT)
Table 100. Direct Channel Pros & Cons
Table 101. Indirect Channel Pros & Cons
Table 102. Antiretroviral Therapy Typical Distributors
Table 103. Antiretroviral Therapy Typical Customers
List of Figures
Figure 1. Antiretroviral Therapy Picture
Figure 2. Global Antiretroviral Therapy Sales Market Share by Type in 2020
Figure 3. NNRTIs
Figure 4. NRTI
Figure 5. Multiclass Combination Products
Figure 6. Integrase Inhibitors
Figure 7. Global Antiretroviral Therapy Sales Market Share by Application in 2020
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Other
Figure 11. Global Antiretroviral Therapy Market Size, (USD Million) & (K MT): 2020 VS 2021 VS 2026
Figure 12. Global Antiretroviral Therapy Market Size and Forecast (2016-2026) & (USD Million)
Figure 13. United States Antiretroviral Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Canada Antiretroviral Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Mexico Antiretroviral Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. Germany Antiretroviral Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. France Antiretroviral Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. United Kingdom Antiretroviral Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Russia Antiretroviral Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Italy Antiretroviral Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. China Antiretroviral Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Japan Antiretroviral Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Korea Antiretroviral Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. India Antiretroviral Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Southeast Asia Antiretroviral Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Australia Antiretroviral Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Brazil Antiretroviral Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Egypt Antiretroviral Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Saudi Arabia Antiretroviral Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. South Africa Antiretroviral Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Turkey Antiretroviral Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 32. Global Antiretroviral Therapy Sales (2016-2026) & (K MT)
Figure 33. Global Antiretroviral Therapy Production Capacity (2016-2026) & (K MT)
Figure 34. Global Antiretroviral Therapy Production Capacity by Geographic Region: 2020 VS 2021
Figure 35. Antiretroviral Therapy Market Drivers
Figure 36. Antiretroviral Therapy Market Restraints
Figure 37. Antiretroviral Therapy Market Trends
Figure 38. Global Antiretroviral Therapy Sales Market Share by Manufacturer in 2020
Figure 39. Global Antiretroviral Therapy Revenue Market Share by Manufacturer in 2020
Figure 40. Antiretroviral Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 41. Top 3 Antiretroviral Therapy Manufacturer (Revenue) Market Share in 2020
Figure 42. Top 6 Antiretroviral Therapy Manufacturer (Revenue) Market Share in 2020
Figure 43. Global Antiretroviral Therapy Sales Market Share by Region (2016-2026)
Figure 44. Global Antiretroviral Therapy Revenue Market Share by Region (2016-2026)
Figure 45. North America Antiretroviral Therapy Revenue (2016-2026) & (USD Million)
Figure 46. Europe Antiretroviral Therapy Revenue (2016-2026) & (USD Million)
Figure 47. Asia-Pacific Antiretroviral Therapy Revenue (2016-2026) & (USD Million)
Figure 48. South America Antiretroviral Therapy Revenue (2016-2026) & (USD Million)
Figure 49. Middle East & Africa Antiretroviral Therapy Revenue (2016-2026) & (USD Million)
Figure 50. Global Antiretroviral Therapy Sales Market Share by Type (2016-2026)
Figure 51. Global Antiretroviral Therapy Revenue Market Share by Type (2016-2026)
Figure 52. Global Antiretroviral Therapy Price by Type (2016-2026) & (USD/MT)
Figure 53. Global Antiretroviral Therapy Sales Market Share by Application (2016-2026)
Figure 54. Global Antiretroviral Therapy Revenue Market Share by Application (2016-2026)
Figure 55. Global Antiretroviral Therapy Price by Application (2016-2026) & (USD/MT)
Figure 56. North America Antiretroviral Therapy Sales Market Share by Country (2016-2026)
Figure 57. North America Antiretroviral Therapy Revenue Market Share by Country (2016-2026)
Figure 58. North America Antiretroviral Therapy Sales Market Share by Type (2016-2026)
Figure 59. North America Antiretroviral Therapy Sales Market Share by Application (2016-2026)
Figure 60. Europe Antiretroviral Therapy Sales Market Share by Country (2016-2026)
Figure 61. Europe Antiretroviral Therapy Revenue Market Share by Country (2016-2026)
Figure 62. Europe Antiretroviral Therapy Sales Market Share by Type (2016-2026)
Figure 63. Europe Antiretroviral Therapy Sales Market Share by Application (2016-2026)
Figure 64. Asia-Pacific Antiretroviral Therapy Sales Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Antiretroviral Therapy Revenue Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Antiretroviral Therapy Sales Market Share by Region (2016-2026)
Figure 67. Asia-Pacific Antiretroviral Therapy Sales Market Share by Application (2016-2026)
Figure 68. South America Antiretroviral Therapy Sales Market Share by Country (2016-2026)
Figure 69. South America Antiretroviral Therapy Revenue Market Share by Country (2016-2026)
Figure 70. South America Antiretroviral Therapy Sales Market Share by Type (2016-2026)
Figure 71. South America Antiretroviral Therapy Sales Market Share by Application (2016-2026)
Figure 72. Middle East & Africa Antiretroviral Therapy Sales Market Share by Country (2016-2026)
Figure 73. Middle East & Africa Antiretroviral Therapy Revenue Market Share by Country (2016-2026)
Figure 74. Middle East & Africa Antiretroviral Therapy Sales Market Share by Type (2016-2026)
Figure 75. Middle East & Africa Antiretroviral Therapy Sales Market Share by Application (2016-2026)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
Figure 77. Methodology
Figure 78. Research Process and Data Source
世界の併用抗体療法市場規模・現状・予測（2021年-2027年） Combination antibody therapy is receiving higher recognition from the oncological branch of medical science research. This is primarily due to the growing use of combination therapy over single drug treatments such as radiation or chemotherapy. In addition, companies that manufacture combination ant…- 世界のエステティック併用療法市場規模・現状・予測（2021年-2027年） Combination treatment in aesthetic market consists of various treatment approaches such as neuromodulators, derma fillers, topical therapies, intense pulsed light photo rejuvenation, laser therapies, radiofrequency-based therapies and ultra-radiofrequency-based therapies. The market is expected to w…
- 世界の免疫細胞療法市場規模・現状・予測（2021年-2027年） Immune therapy is a new class of cancer treatment designed to boost or enhance the body’s immune system to more efficiently target and destroy cancerous cells. Many experts believe that immunotherapy represents the most promising new cancer treatment since the development of chemotherapy. Market Ana…
- 世界の外来用点滴療法サービス市場規模・現状・予測（2021年-2027年） Infusion therapy involves the administration of medication through a needle or catheter. It is prescribed when a patient’s condition is so severe that it cannot be treated effectively by oral medications. Ambulatory infusion therapy is a flourishing nationwide trend. Due to a confluence of health ca…
- 世界の変形性関節症幹細胞治療市場規模・現状・予測（2021年-2027年） Osteoarthritis is one of the chronic conditions for joints which results in the breakdown and eventual loss of the cartilage of one or more joints. This can affect joints including hips, lower back, neck, small joints of the fingers, and the base of the thumb and big toe. The expected growth is beca…